Frontiers in Pharmacology | Pharmacogenetics and Pharmacogenomics

Original Research

Accepted on 07 Jul 2025

Population-Specific Genetic Differences of Acute Coronary Syndrome in Han and Uyghur Chinese

in Pharmacogenetics and Pharmacogenomics

Hongmei Lai
Jinhang Zhu
Jing Tao
Zitong Guo
Xiaolin Yu
Xin Shen
Ting Wang
Ying Wang
Huan Cai
Xiao Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1588658

138 views

Review

Accepted on 07 Jul 2025

Epigenetic Modifications of Gut Microbiota and Their Potential Role in Atherosclerosis

in Pharmacogenetics and Pharmacogenomics

Shuang Guo
Junlai Zhao
Rongrong Zhu
Zhi Fan
Shibiao Liu
Weiwei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1638240

131 views

Editorial

Published on 07 Jul 2025

Editorial: Post-translational modifications in human cancer: pharmacological insights and therapeutic opportunities

in Pharmacogenetics and Pharmacogenomics

Yongzhi Chen
Angelina W. Fan
Lei Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1654659

306 views

Mini Review

Accepted on 04 Jul 2025

Statins and their impact on epigenetic regulation: insights into disease

in Pharmacogenetics and Pharmacogenomics

Rafael Tamayo-Trujillo
Patricia Guevara-Ramírez
Santiago Cadena-Ullauri
Viviana A. Ruiz-Pozo
Elius Andrés Paz Cruz
Ana Karina Zambrano

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621163

319 views

Editorial

Accepted on 04 Jul 2025

Editor's Feature: Negative Findings in Pharmacogenetics and Pharmacogenomics Volume II

in Pharmacogenetics and Pharmacogenomics

José A G Agúndez
Elena García-Martín
Luis Abel Quiñones

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1658876

123 views

Original Research

Published on 04 Jul 2025

Exploring biomarkers for noise-induced hearing loss through mitochondrial DNA methylation analysis

in Pharmacogenetics and Pharmacogenomics

Dianpeng Wang
Caiping Li
Liuwei Shi
Dafeng Lin
Shaofan Weng
Xiangli Yang
Peimao Li
Zhimin Zhang
Wen Zhang
Yan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561791

704 views

Editorial

Published on 01 Jul 2025

Editorial: Pharmacogenomics for improving drug safety and efficacy in cancer

in Pharmacogenetics and Pharmacogenomics

Zhiyao He
Xuewei Fu
Zhijie Xu
Omar Alshargi
Roberto Rodríguez-Labrada
Xiao-Bo Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1649258

412 views

Original Research

Accepted on 27 Jun 2025

Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period

in Pharmacogenetics and Pharmacogenomics

Junwei Fan
Peihao Wen
Liyun Yuan
Yan Xia
Shijie Hu
Xiaoqing Zhang
Zhihai Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614753

143 views

Systematic Review

Accepted on 20 Jun 2025

Polymorphisms in CYP3A5, CYP3A4, and ABCB1 Genes: Implications for Calcineurin Inhibitors Therapy in Hematopoietic Cell Transplantation Recipients-A Systematic Review

in Pharmacogenetics and Pharmacogenomics

Luiz Carlos da Costa-Junior
Daniely Regina Freitas-Alves
Amanda Melo Leite Leão
Hayra de Andrade Vieira Monterio
Rita de Cássia Barbosa da Silva Tavares
Maria Claudia Rodrigues Moreira
Marília Berlofa Visacri
Teresa de Souza Fernandez
Paulo Caleb J L Santos

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1569353

207 views

Systematic Review

Published on 19 Jun 2025

CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis

in Pharmacogenetics and Pharmacogenomics

Harri Hardi
Agian Jeffilano Barinda
Liganda Endo Mahata
Zahra Fitrianti

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572886

931 views

Systematic Review

Accepted on 14 Jun 2025

Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: A systematic review and meta-analysis

in Pharmacogenetics and Pharmacogenomics

Ling Yin Fritz Wong
Alastair G. Sutcliffe
Carmen Lok Tung Ho
Yan Lu
Carrie L. Williams
Faiza Afzal
Mitana Purkayastha

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1568320

400 views

Review

Accepted on 13 Jun 2025

Global Variation in Antibiotic Prescribing Guidelines and the implications for decreasing AMR in the future

in Pharmacogenetics and Pharmacogenomics

Emmama Jamil
Zikria Saleem
Brian Godman
Matti Ullah
Afreenish Hassan
Abdul Haseeb
Johanna Catharina Meyer
Muhammad Usman Qamar
Safa Almarzoky Abuhussain

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1600787

247 views

Original Research

Published on 13 Jun 2025

Hsa_circ_0002238 promotes the malignant behavior of colorectal cancer

in Pharmacogenetics and Pharmacogenomics

Lin-Ting Zhang
Yuejia Zhou
Tiantian Wang
Boran Chen
Zhigao Cai
Shubin Wang
Gangling Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541820

558 views

Original Research

Published on 04 Jun 2025

Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study

in Pharmacogenetics and Pharmacogenomics

Sireen Abdul Rahim Shilbayeh
Naglaa F. Khedr
Mohammad A. Alshabeeb
Abdulmonem Ali Alsaleh
Abdalrhman Hamdan Alanizi
Omnia A. Abd El-Baset
Rehab H. Werida

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604473

1,351 views

Original Research

Published on 03 Jun 2025

Exosomal miR-24-3p mediates myoblast-macrophage crosstalk to promote abdominal muscle repair

in Pharmacogenetics and Pharmacogenomics

Yuchen Liu
Zhenyu Zou
Jinxin Cao
Tong Zhu
Yilin Zhu
Yingmo Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604776

890 views

Brief Research Report

Published on 23 May 2025

Dynamic star allele definitions in Pharmacogenomics: impact on diplotype calls, Phenotype predictions and statin therapy recommendations

in Pharmacogenetics and Pharmacogenomics

Sven van der Maas
Simon Denil
Brigitte Maes
Gökhan Ertaylan
Pieter-Jan Volders

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584658

992 views